bioAffinity Technologies, Inc. - Common Stock - Nakit Akışı (NASDAQ:BIAF) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -4.07 M-6.04 M-7.26 M-9.33 M -10.91 M Yatırım faaliyetlerinden elde edilen nakit -219.99 K-2.21 M-79.08 K-60.57 K -15.45 K Finansman faaliyetlerinden elde edilen nakit 14.34 M-344.98 K5.63 M14.73 M 13.58 M Serbest nakit akışı -4.07 M-6.04 M-7.26 M-9.39 M -10.93 M

Haberler

BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung

bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?

bioAffinity Technologies, Inc. (BIAF) Discusses Clinical Integration of CyPath Lung in Pulmonary Nodule Assessment and Early Lung Cancer Diagnosis Transcript

bioAffinity’nin akciğer testi satışları 1. çeyrekte %146 arttı

What's Going On With bioAffinity Technologies Stock Wednesday? - bioAffinity Technologies (NASDAQ:BIAF)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

Why Is bioAffinity Technologies Stock Surging Tuesday? - bioAffinity Technologies (NASDAQ:BIAF)

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25%

bioAffinity Technologies 2025 mali sonuçlarını açıkladı

bioAffinity Technologies reports 2025 financial results

bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth - bioAffinity Technologies (NASDAQ:BIAF)

BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?